-
-
-
-
-
-
-
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
-
-
-
-
-
-
-
Caladrius Biosciences announces Purchase Agreement with Lincoln Park Capital for up to $26 million
-
-
-
-
-
-
-
Form S-3 Caladrius Biosciences,
68,144 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

